Congress Weighs Repeal of Tax Credit for Rare Disease Drugs
A decades-old tax credit designed to spur cures for rare diseases has been so successful that it’s now become a target in the House Republican tax plan.
The proposal under consideration would end the tax breaks for development of what are called orphan drugs.
Ending the credit used by big and small drug companies could save the government an estimated $54 billion over the next decade,
an effort to help offset some of the anticipated losses in revenue if other Republican tax cut provisions become law.
https://www.nytimes.com/2017/11/08/h...er=rss&emc=rss
Repug philosophy,
"if govt actually does something good, that violates our philosophy, so we must stop govt from doing good. NOTHING good from come govt"

Reply With Quote

